top of page
Image-empty-state_edited.jpg

AMASS

AMASS Botanics Stock 1
Portfolio of premium, high-growth botanic beverages and self care products

?/100

Crowd Score
There is a newer open investment round for this company - click here to view
Our take:
AMASS carries an eyepopping $75m valuation, or 22x 2020 revenue. In addition, the company just closed (3/3/2021) an $11m convertible note at a $38m valuation cap - less than 3 weeks prior to this round doubling the valuation. AMASS has competition from Haus and other brands attacking online alcohol sales by using low-ABV products to skirt regulations. 

Thanks, catch you soon!

Sign up to receive weekly deal alerts and top news

Round Performance

Amount Raised

[]

Average-Investment-Icon-p-1600.png
Average Investment

[]

Average-Daily-Investment-Icon-p-1600.png
Average Per Day

[]

Investors-Icon-p-1600.png
# of Investors

[]

Investors vs. Capital Raised

Investment Type

Preferred Stock

Round Valuation

$75,000,000

Minimum Investment

$499

Price Per Share

$3.8654

Investment Details

Early Bird Perks

Perk description
Perk level (dollars)
Perk level (days)
Loading...

No early bird perks for this round!

Screen Shot 2020-07-15 at 12.01.28 PM.pn

View early bird perks, company financials, valuation methods, and more

Similar Investments

Image-empty-state_edited.jpg
Geoship
SAFE
Image-empty-state_edited.jpg
KALIA HEALTH
Image-empty-state_edited.jpg
OPTICYTE
bottom of page